- NEWS AND VIEWS
Antitumour T cells stand the test of time
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 576, 392-393 (2019)
doi: https://doi.org/10.1038/d41586-019-03731-w
References
Wei, J. et al. Nature 576, 471–476 (2019).
Lim, W. A. & June, C. H. Cell 168, 724–740 (2017).
Henning, A. N., Roychoudhuri, R. & Restifo, N. P. Nature Rev. Immunol. 18, 340–356 (2018).
Zhang, L. & Romero, P. Trends Mol. Med. 24, 30–48 (2018).
Matsushita, K. et al. Nature 458, 1185–1190 (2009).
Iwasaki, H. et al. Nature Immunol. 12, 1167–1175 (2011).
Uehata, T. et al. Cell 153, 1036–1049 (2013).
Scharping, N. E. et al. Immunity 45, 701–703 (2016).
Kurachi, M. et al. Nature Immunol. 15, 373–383 (2014).
Miller, B. C. et al. Nature Immunol. 20, 326–336 (2019).
Manguso, R. T. et al. Nature 547, 413–418 (2017).
Competing Interests
A.W.G. is on the SAB of Pandion Therapeutics and Arsenal Bio.